TCL Archive In Brief: Medical School Deans Biggest Enemy Of Cancer Program, Saunders Says; House Oks Line Item May 16, 1980
TCL Archive NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection November 7, 1980
TCL Archive In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th July 27, 1984
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
